These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6692287)

  • 1. The effect of tamoxifen on bone mineral content in premenopausal women with breast cancer.
    Gotfredsen A; Christiansen C; Palshof T
    Cancer; 1984 Feb; 53(4):853-7. PubMed ID: 6692287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years.
    Love RR; Mazess RB; Tormey DC; Barden HS; Newcomb PA; Jordan VC
    Breast Cancer Res Treat; 1988 Dec; 12(3):297-302. PubMed ID: 3228591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of vitamin D metabolism and bone mineral content after intestinal bypass for obesity. A longitudinal study.
    Rickers H; Christiansen C; Balslev I; Rødbro P
    Scand J Gastroenterol; 1984 Mar; 19(2):184-9. PubMed ID: 6609420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study.
    Kristensen B; Ejlertsen B; Dalgaard P; Larsen L; Holmegaard SN; Transbøl I; Mouridsen HT
    J Clin Oncol; 1994 May; 12(5):992-7. PubMed ID: 8164053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral content of women receiving tamoxifen for mastalgia.
    Fentiman IS; Caleffi M; Rodin A; Murby B; Fogelman I
    Br J Cancer; 1989 Aug; 60(2):262-4. PubMed ID: 2765377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane.
    Gonnelli S; Cadirni A; Caffarelli C; Petrioli R; Montagnani A; Franci MB; Lucani B; Francini G; Nuti R
    Bone; 2007 Jan; 40(1):205-10. PubMed ID: 16904960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral content and estrogen receptors in women with breast tumors.
    Nielsen HE; Saksø P; Skorgaard Poulsen H; Gadeberg CC
    Acta Radiol Oncol; 1985; 24(3):247-51. PubMed ID: 2994375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tamoxifen on spinal bone density in women with breast cancer.
    Turken S; Siris E; Seldin D; Flaster E; Hyman G; Lindsay R
    J Natl Cancer Inst; 1989 Jul; 81(14):1086-8. PubMed ID: 2738937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer.
    Zidan J; Keidar Z; Basher W; Israel O
    Med Oncol; 2004; 21(2):117-21. PubMed ID: 15299183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients.
    Marttunen MB; Hietanen P; Tiitinen A; Ylikorkala O
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1158-62. PubMed ID: 9543133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: preliminary study.
    Ryan WG; Wolter J; Bagdade JD
    Osteoporos Int; 1991 Oct; 2(1):39-41. PubMed ID: 1790419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
    Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
    J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
    Vehmanen L; Elomaa I; Blomqvist C; Saarto T
    J Clin Oncol; 2006 Feb; 24(4):675-80. PubMed ID: 16446340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium homeostasis and mineralization in puberty.
    Krabbe S
    Dan Med Bull; 1989 Apr; 36(2):113-24. PubMed ID: 2651027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.
    Canon J; Bryant R; Roudier M; Branstetter DG; Dougall WC
    Breast Cancer Res Treat; 2012 Oct; 135(3):771-80. PubMed ID: 22926264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral content in patients with carcinoma of the prostate.
    Mobb GE; Moisey CU; Ring EF
    Br J Urol; 1988 Oct; 62(4):355-8. PubMed ID: 3191361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral content before and after intestinal bypass operation in obese patients.
    Rickers H; Balslev I; Foltved H; Rødbro P
    Acta Med Scand; 1981; 209(3):203-7. PubMed ID: 7223514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total and local bone mineral during estrogen treatment: a placebo controlled trial.
    Gotfredsen A; Riis BJ; Christiansen C
    Bone Miner; 1986 Apr; 1(2):167-73. PubMed ID: 3334206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.
    Powles TJ; Hickish T; Kanis JA; Tidy A; Ashley S
    J Clin Oncol; 1996 Jan; 14(1):78-84. PubMed ID: 8558225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral content in patients on prolonged maintenance hemodialysis: a three year follow-up study.
    Rickers H; Christensen M; Rødbro P
    Clin Nephrol; 1983 Dec; 20(6):302-7. PubMed ID: 6641032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.